- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Circuits to Shape Natural Killer Cells in Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 13, Pages 3225
Publisher
MDPI AG
Online
2021-06-28
DOI
10.3390/cancers13133225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
- (2021) Silvia Gaggero et al. Frontiers in Immunology
- Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
- (2021) Johanna Bödder et al. Frontiers in Immunology
- Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy
- (2021) Martina Molgora et al. Cancers
- Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation
- (2021) Adelle P. McFarland et al. IMMUNITY
- Tissues, not blood, are where immune cells function
- (2021) Donna L. Farber NATURE
- Tissue Determinants of Human NK Cell Development, Function, and Residence
- (2020) Pranay Dogra et al. CELL
- NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists
- (2020) Christopher J. Nicolai et al. Science Immunology
- The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
- (2020) Tobias Bald et al. NATURE IMMUNOLOGY
- ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung
- (2020) Martijn J. Schuijs et al. NATURE IMMUNOLOGY
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- NK Cell Development in Times of Innate Lymphoid Cell Diversity
- (2020) Vladislava Stokic-Trtica et al. Frontiers in Immunology
- Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
- (2020) Yuhui Yang et al. Frontiers in Immunology
- Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
- (2020) Eduardo Bonavita et al. IMMUNITY
- Multidimensional molecular controls defining NK/ILC1 identity in cancers
- (2020) Adeline Crinier et al. SEMINARS IN IMMUNOLOGY
- Natural killers or ILC1s? That is the question
- (2020) Cyril Seillet et al. CURRENT OPINION IN IMMUNOLOGY
- Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
- (2019) Laurent Gauthier et al. CELL
- A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44
- (2019) Annika Niehrs et al. NATURE IMMUNOLOGY
- The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell–mediated resistance to metastasis
- (2019) Irene Mattiola et al. NATURE IMMUNOLOGY
- Natural killer cell recruitment and activation are regulated by CD47 expression in the tumor microenvironment
- (2019) Pulak Ranjan Nath et al. Cancer Immunology Research
- Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
- (2019) Antonino Bruno et al. Frontiers in Immunology
- Therapeutic blockade of activin-A improves NK cell function and antitumor immunity
- (2019) Jai Rautela et al. Science Signaling
- NK Cell Metabolism and Tumor Microenvironment
- (2019) Iñigo Terrén et al. Frontiers in Immunology
- Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment
- (2019) Ramouna Voshtani et al. CANCER LETTERS
- Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases
- (2019) Prakash Babu Narasimhan et al. JOURNAL OF IMMUNOLOGY
- Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
- (2019) Xiaohu Zheng et al. NATURE IMMUNOLOGY
- NK Cell-Based Immunotherapy for Hematological Malignancies
- (2019) Simona Sivori et al. Journal of Clinical Medicine
- Interleukin‐33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development
- (2019) Lu Qi et al. INTERNATIONAL JOURNAL OF CANCER
- The Platelet Lifeline to Cancer: Challenges and Opportunities
- (2018) Monika Haemmerle et al. CANCER CELL
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
- (2018) Lucas Ferrari de Andrade et al. SCIENCE
- NKG2D and Its Ligands: “One for All, All for One”
- (2018) Alessandra Zingoni et al. Frontiers in Immunology
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus
- (2018) Pulak Ranjan Nath et al. Frontiers in Immunology
- NK Cell-Based Immunotherapy in Cancer Metastasis
- (2018) Seila Lorenzo-Herrero et al. Cancers
- The ILC World Revisited
- (2017) Andreas Diefenbach et al. IMMUNITY
- IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
- (2017) Martina Molgora et al. NATURE
- Primary Tumors Limit Metastasis Formation through Induction of IL15-Mediated Cross-Talk between Patrolling Monocytes and NK Cells
- (2017) Hiroshi Kubo et al. Cancer Immunology Research
- Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer
- (2017) Liu-sheng Peng et al. Cancer Immunology Research
- Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
- (2017) Stefanie Maurer et al. OncoImmunology
- Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
- (2016) Qiong-Fang Zhang et al. Cellular & Molecular Immunology
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- NK cells and type 1 innate lymphoid cells: partners in host defense
- (2016) Hergen Spits et al. NATURE IMMUNOLOGY
- Evidence of innate lymphoid cell redundancy in humans
- (2016) Frédéric Vély et al. NATURE IMMUNOLOGY
- IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs
- (2016) Suzanne M Bal et al. NATURE IMMUNOLOGY
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
- (2016) A. Spiegel et al. Cancer Discovery
- Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency
- (2016) Mikael Ebbo et al. EBioMedicine
- Patrolling monocytes control tumor metastasis to the lung
- (2015) R. N. Hanna et al. SCIENCE
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30
- (2014) E. Schlecker et al. CANCER RESEARCH
- Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages
- (2014) Christoph S.N. Klose et al. CELL
- Innate lymphoid cells facilitate NK cell development through a lymphotoxin-mediated stromal microenvironment
- (2014) Tae-Jin Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- NK Cell Phenotypic Modulation in Lung Cancer Environment
- (2014) Shi Jin et al. PLoS One
- Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
- (2014) Talib Hassan Ali et al. Nature Communications
- Interleukin-17D Mediates Tumor Rejection through Recruitment of Natural Killer Cells
- (2014) Timothy O’Sullivan et al. Cell Reports
- Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses
- (2014) Shiho Chiba et al. eLife
- Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
- (2013) N. Fiegler et al. BLOOD
- Neuroblastoma-Derived TGF- 1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
- (2013) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- A T-bet gradient controls the fate and function of CCR6−RORγt+ innate lymphoid cells
- (2013) Christoph S. N. Klose et al. NATURE
- Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
- (2013) Jochem H Bernink et al. NATURE IMMUNOLOGY
- Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
- (2012) Jaclyn Sceneay et al. CANCER RESEARCH
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
- (2012) G. Erdag et al. CANCER RESEARCH
- Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor
- (2012) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1
- (2012) A. Glasner et al. JOURNAL OF IMMUNOLOGY
- GITR Ligand Provided by Thrombopoietic Cells Inhibits NK Cell Antitumor Activity
- (2012) T. Placke et al. JOURNAL OF IMMUNOLOGY
- Monocytes control natural killer cell differentiation to effector phenotypes
- (2011) K. Soderquest et al. BLOOD
- Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
- (2011) T. Placke et al. CANCER RESEARCH
- Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
- (2011) N. Halama et al. CLINICAL CANCER RESEARCH
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- Distinct Phenotype and Function of NK Cells in the Pancreas of Nonobese Diabetic Mice
- (2010) Hanna Brauner et al. JOURNAL OF IMMUNOLOGY
- MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
- (2010) Jennifer AA Gubbels et al. Molecular Cancer
- IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46
- (2010) Maya Eisenring et al. NATURE IMMUNOLOGY
- Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
- (2010) J. D. Shields et al. SCIENCE
- Platelet-Derived Transforming Growth Factor- Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
- (2009) H.-G. Kopp et al. CANCER RESEARCH
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients
- (2009) Philippe O. Gannon et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells
- (2008) N. Nausch et al. BLOOD
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- Expression of Ligands to NKp46 in Benign and Malignant Melanocytes
- (2007) Emanuela Cagnano et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now